BIO KEY INTERNATIONAL INC short interest in 2021
In 2021, BIO KEY INTERNATIONAL INC's disclosed short interest ran from 12.97% of shares outstanding on 31 Mar 2021 to 1.14% on 31 Dec 2021, a change of -11.83 percentage points. The year's high was 12.97% on 31 Mar 2021 and its low 1.14% on 31 Dec 2021, averaging 4.60% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.20 days on 13 Aug 2021. Full history: BIO KEY INTERNATIONAL INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2021 in figures
- Start of year
- 12.97% (31 Mar 2021)
- End of year
- 1.14% (31 Dec 2021)
- Change
- -11.83 pp
- High
- 12.97% (31 Mar 2021)
- Low
- 1.14% (31 Dec 2021)
- Average
- 4.60%
- Highest days to cover
- 8.20 (13 Aug 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 31 Mar 2021 | 12.97% | 1.46 | results (8-K), 10-K filed |
| 15 Apr 2021 | 10.36% | 3.55 | |
| 30 Apr 2021 | 9.28% | 6.34 | |
| 14 May 2021 | 7.26% | 4.50 | results (8-K) |
| 28 May 2021 | 6.23% | 2.48 | 10-Q filed |
| 15 Jun 2021 | 4.77% | 5.04 | |
| 30 Jun 2021 | 4.04% | 2.86 | |
| 15 Jul 2021 | 3.93% | 3.07 | |
| 30 Jul 2021 | 4.51% | 3.88 | |
| 13 Aug 2021 | 4.24% | 8.20 | |
| 31 Aug 2021 | 4.02% | 4.69 | 10-Q filed, results (8-K) |
| 15 Sep 2021 | 3.79% | 4.88 | |
| 30 Sep 2021 | 3.17% | 1.00 | |
| 15 Oct 2021 | 1.84% | 1.88 | |
| 29 Oct 2021 | 1.48% | 2.90 | |
| 15 Nov 2021 | 1.32% | 2.30 | 10-Q filed |
| 30 Nov 2021 | 1.78% | 1.23 | results (8-K) |
| 15 Dec 2021 | 1.18% | 2.12 | |
| 31 Dec 2021 | 1.14% | 1.74 |
See also: BIO KEY INTERNATIONAL INC's full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.